Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 854265, 16 pages
http://dx.doi.org/10.1155/2015/854265
Review Article

Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story

1Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH 43210, USA
2Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA
3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Cairo, Egypt

Received 1 January 2015; Accepted 7 March 2015

Academic Editor: Vladimir Jakovljevic

Copyright © 2015 Mohammad T. Elnakish et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Elnakish, H. H. Hassanain, P. M. Janssen, M. G. Angelos, and M. Khan, “Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase,” Journal of Pathology, vol. 231, no. 3, pp. 290–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. S. Petrulea, I. Duncea, and A. Muresan, “Thyroid hormones in excess induce oxidative stress in rats,” Acta Endocrinologica, vol. 5, no. 2, pp. 155–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Messarah, M. S. Boulakoud, A. Boumendjel, C. Abdennour, and A. El Feki, “The impact of thyroid activity variations on some oxidizing-stress parameters in rats,” Comptes Rendus Biologies, vol. 330, no. 2, pp. 107–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Nordberg and E. S. J. Arnér, “Reactive oxygen species, antioxidants, and the mammalian thioredoxin system,” Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1287–1312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Sies, “Oxidative stress: oxidants and antioxidants,” Experimental Physiology, vol. 82, no. 2, pp. 291–295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. B. C. Freeman and J. D. Crapo, “Biology of disease. Free radicals and tissue injury,” Laboratory Investigation, vol. 47, no. 5, pp. 412–426, 1982. View at Google Scholar · View at Scopus
  7. B. Halliwell and J. M. C. Gutteridge, “Role of free radicals and catalytic metal ions in human disease: an overview,” Methods in Enzymology, vol. 186, pp. 1–85, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Asayama and K. Kato, “Oxidative muscular injury and its relevance to hyperthyroidism,” Free Radical Biology and Medicine, vol. 8, no. 3, pp. 293–303, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Villanueva, C. Alva-Sánchez, and J. Pacheco-Rosado, “The role of thyroid hormones as inductors of oxidative stress and neurodegeneration,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 218145, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. De, G. Ghosh, M. Datta et al., “Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray,” The Journal of Endocrinology, vol. 182, no. 2, pp. 303–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Klein and S. Danzi, “Thyroid disease and the heart,” Circulation, vol. 116, no. 15, pp. 1725–1735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Kuzman, K. A. Vogelsang, T. A. Thomas, and A. M. Gerdes, “L-Thyroxine activates Akt signaling in the heart,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 2, pp. 251–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Degens, A. J. Gilde, M. Lindhout, P. H. M. Willemsen, G. J. van der Vusse, and M. van Bilsen, “Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 1, pp. H108–H115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Gredilla, G. Barja, and M. López-Torres, “Thyroid hormone-induced oxidative damage on lipids, glutathione and DNA in the mouse heart,” Free Radical Research, vol. 35, no. 4, pp. 417–425, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Elnakish, M. M. Awad, M. D. H. Hassona et al., “Cardiac remodeling caused by transgenic overexpression of a corn Rac gene,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 3, pp. H868–H880, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. T. Elnakish, M. D. H. Hassona, M. A. Alhaj et al., “Rac-induced left ventricular dilation in thyroxin-treated zmracd transgenic mice: role of cardiomyocyte apoptosis and myocardial fibrosis,” PLoS ONE, vol. 7, no. 8, Article ID e42500, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. T. Elnakish, L. Moldovan, M. Khan, H. H. Hassanain, and P. M. L. Janssen, “Myocardial Rac1 exhibits partial involvement in thyroxin-induced cardiomyocyte hypertrophy and its inhibition is not sufficient to improve cardiac dysfunction or contractile abnormalities in mouse papillary muscles,” Journal of Cardiovascular Pharmacology, vol. 61, no. 6, pp. 536–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. R. Araujo, M. F. M. Ribeiro, A. Enzveiler et al., “Myocardial antioxidant enzyme activities and concentration and glutathione metabolism in experimental hyperthyroidism,” Molecular and Cellular Endocrinology, vol. 249, no. 1-2, pp. 133–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. R. Araujo, A. T. Enzveiler, P. Schenkel et al., “Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine,” Molecular and Cellular Biochemistry, vol. 303, no. 1-2, pp. 89–95, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. R. Araujo, P. Schenkel, A. T. Enzveiler et al., “The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism,” Journal of Molecular Endocrinology, vol. 41, no. 5-6, pp. 423–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Kuzman, T. A. Thomas, K. A. Vogelsang, S. Said, B. E. Anderson, and A. M. Gerdes, “Effects of induced hyperthyroidism in normal and cardiomyopathic hamsters,” Journal of Applied Physiology, vol. 99, no. 4, pp. 1428–1433, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. R. Araujo, T. Fernandes, M. F. Ribeiro, N. Khaper, and A. Belló-Klein, “Redox regulation of myocardial Erk 1/2 phosphorylation in experimental hyperthyroidism: role of thioredoxin-peroxiredoxin system,” Journal of Cardiovascular Pharmacology, vol. 56, no. 5, pp. 513–517, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. S. R. Araujo, G. P. Diniz, F. E. R. Seibel et al., “Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system,” Molecular and Cellular Endocrinology, vol. 333, no. 1, pp. 78–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. R. O. Fernandes, G. J. Dreher, P. C. Schenkel et al., “Redox status and pro-survival/pro-apoptotic protein expression in the early cardiac hypertrophy induced by experimental hyperthyroidism,” Cell Biochemistry and Function, vol. 29, no. 7, pp. 617–623, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Asayama, K. Dobashi, H. Hayashibe, and K. Kato, “Vitamin E protects against thyroxine-induced acceleration of lipid peroxidation in cardiac and skeletal muscles in rats,” Journal of Nutritional Science and Vitaminology, vol. 35, no. 5, pp. 407–418, 1989. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Moreno, I. Rodríguez Gómez, R. Wangensteen, A. Osuna, P. Bueno, and F. Vargas, “Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 289, no. 5, pp. E776–E783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Rodríguez-Gómez, J. Sainz, R. Wangensteen et al., “Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats,” Hypertension, vol. 42, no. 2, pp. 220–225, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Rodríguez-Gómez, R. Wangensteen, J. M. Moreno, V. Chamorro, A. Osuna, and F. Vargas, “Effects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats,” American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 6, pp. E1252–E1257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Wangensteen, I. Rodríguez-Gómez, J. M. Moreno, M. Álvarez-Guerra, A. Osuna, and F. Vargas, “Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 291, no. 5, pp. R1376–R1382, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Riaz, A. D. Forker, W. L. Isley, M. S. Hamburg, and P. A. McCullough, “Hyperthyroidism: a ‘curable’ cause of congestive heart failure—three case reports and a review of the literature,” Congestive Heart Failure, vol. 9, no. 1, pp. 40–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. G. E. Umpierrez, S. Challapalli, and C. Patterson, “Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism,” The American Journal of the Medical Sciences, vol. 310, no. 3, pp. 99–102, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. L. E. A. Wildemberg, L. L. de Sousa, L. P. M. da Fonseca, and M. V. L. de Souza, “Reversible dilated cardiomyopathy related to hyperthyroidism,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 51, no. 9, pp. 1533–1538, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. V. M. Rodríguez Blanco, V. Barriales Álvarez, E. Segovia Martínez, C. M. de la Tassa, R. Barriales Villa, and A. C. Llosa, “Reversible dilated cardiomyopathy and thyrotoxicosis,” Revista Española de Cardiología, vol. 49, no. 10, pp. 770–772, 1996. View at Google Scholar · View at Scopus
  34. R. W. Tsika, J. J. Bahl, L. A. Leinwand, and E. Morkin, “Thyroid hormone regulates expression of a transfected human α-myosin heavy-chain fusion gene in fetal rat heart cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 1, pp. 379–383, 1990. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Zarain-Herzberg, J. Marques, and D. Sukovich, “Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco(endo)plasmic reticulum Ca2+-ATPase gene,” The Journal of Biological Chemistry, vol. 269, no. 2, pp. 1460–1467, 1994. View at Google Scholar
  36. J. Orlowski and J. B. Lingrel, “Thyroid and glucocorticoid hormones regulate the expression of multiple Na,K-ATPase genes in cultured neonatal rat cardiac myocytes,” The Journal of Biological Chemistry, vol. 265, no. 6, pp. 3462–3470, 1990. View at Google Scholar · View at Scopus
  37. S. W. Bahouth, “Thyroid hormones transcriptionally regulate the β1-adrenergic receptor gene in cultured ventricular myocytes,” The Journal of Biological Chemistry, vol. 266, no. 24, pp. 15863–15869, 1991. View at Google Scholar · View at Scopus
  38. M. J. Fullerton, S. Stuchbury, Z. S. Krozowski, and J. W. Funder, “Altered thyroidal status and the in vivo synthesis of atrial natriuretic peptide in the rat heart,” Molecular and Cellular Endocrinology, vol. 69, no. 2-3, pp. 227–233, 1990. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Averyhart-Fullard, L. D. Fraker, A. M. Murphy, and R. J. Solaro, “Differential regulation of slow-skeletal and cardiac troponin I mRNA during development and by thyroid hormone in rat heart,” Journal of Molecular and Cellular Cardiology, vol. 26, no. 5, pp. 609–616, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Morkin, “Regulation of myosin heavy chain genes in the heart,” Circulation, vol. 87, no. 5, pp. 1451–1460, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Mishra and L. Samanta, “Oxidative stress and heart failure in altered thyroid states,” The Scientific World Journal, vol. 2012, Article ID 741861, 17 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. J. Bergh, H.-Y. Lin, L. Lansing et al., “Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis,” Endocrinology, vol. 146, no. 7, pp. 2864–2871, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Asayama, K. Dobashi, H. Hayashibe, Y. Megata, and K. Kato, “Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism,” Endocrinology, vol. 121, no. 6, pp. 2112–2118, 1987. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Asayama, K. Dobashi, H. Hayashibe, and K. Kato, “Effects of beta-adrenergic blockers with different ancillary properties on lipid peroxidation in hyperthyroid rat cardiac muscle,” Endocrinologia Japonica, vol. 36, no. 5, pp. 687–694, 1989. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Shinohara, T. Mano, A. Nagasaka et al., “Lipid peroxidation levels in rat cardiac muscle are affected by age and thyroid status,” The Journal of Endocrinology, vol. 164, no. 1, pp. 97–102, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Mano, R. Sinohara, Y. Sawai et al., “Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle,” Journal of Endocrinology, vol. 145, no. 1, pp. 131–136, 1995. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Civelek, O. Seymen, A. Seven, G. Yiǧit, H. Hatemi, and G. Burçak, “Oxidative stress in heart tissue of hyperthyroid and iron supplemented rats,” Journal of Toxicology and Environmental Health, Part A, vol. 64, no. 6, pp. 499–506, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Venditti, M. Balestrieri, S. di Meo, and T. de Leo, “Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues,” The Journal of Endocrinology, vol. 155, no. 1, pp. 151–157, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Mogulkoc, A. K. Baltaci, L. Aydin, E. Oztekin, and A. Sivrikaya, “The effect of thyroxine administration on lipid peroxidation in different tissues of rats with hypothyroidism,” Acta Physiologica Hungarica, vol. 92, no. 1, pp. 39–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. M. Mohamadin, L. N. A. Hammad, M. F. El-Bab, and H. S. Abdel Gawad, “Attenuation of oxidative stress in plasma and tissues of rats with experimentally induced hyperthyroidism by caffeic acid phenylethyl ester,” Basic & Clinical Pharmacology & Toxicology, vol. 100, no. 2, pp. 84–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Ikeda, N. Hamada, H. Morii, M. Inaba, and J. Yamakawa, “Serum and tissue coenzyme Q9 in rats with thyroid dysfunctions,” Hormone and Metabolic Research, vol. 16, no. 11, pp. 585–588, 1984. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Venditti, T. De Leo, and S. Di Meo, “Vitamin E administration attenuates the tri-iodothyronine-induced modification of heart electrical activity in the rat,” The Journal of Experimental Biology, vol. 200, no. 5, pp. 909–914, 1997. View at Google Scholar · View at Scopus
  53. P. Venditti, T. de Leo, and S. di Meo, “Antioxidant-sensitive shortening of ventricular action potential in hyperthyroid rats is independent of lipid peroxidation,” Molecular and Cellular Endocrinology, vol. 142, no. 1-2, pp. 15–23, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Venditti and S. di Meo, “Thyroid hormone-induced oxidative stress,” Cellular and Molecular Life Sciences, vol. 63, no. 4, pp. 414–434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Yamada, T. Mishima, M. Sakamoto, M. Sugiyama, S. Matsunaga, and M. Wada, “Myofibrillar protein oxidation and contractile dysfunction in hyperthyroid rat diaphragm,” Journal of Applied Physiology, vol. 102, no. 5, pp. 1850–1855, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. T. Elnakish, E. J. Schultz, R. L. Gearinger et al., “Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles,” Free Radical Biology and Medicine, vol. 83, pp. 252–261, 2015. View at Publisher · View at Google Scholar
  57. T. Ide, H. Tsutsui, S. Kinugawa et al., “Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium,” Circulation Research, vol. 86, no. 2, pp. 152–157, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Ide, H. Tsutsui, S. Hayashidani et al., “Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction,” Circulation Research, vol. 88, no. 5, pp. 529–535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Nishiki, M. Erecinska, D. F. Wilson, and S. Cooper, “Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats,” The American Journal of Physiology—Cell Physiology, vol. 4, no. 3, pp. C212–C219, 1978. View at Google Scholar · View at Scopus
  60. J. F. Turrens, A. Alexandre, and A. L. Lehninger, “Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria,” Archives of Biochemistry and Biophysics, vol. 237, no. 2, pp. 408–414, 1985. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Chance, H. Sies, and A. Boveris, “Hydroperoxide metabolism in mammalian organs,” Physiological Reviews, vol. 59, no. 3, pp. 527–605, 1979. View at Google Scholar · View at Scopus
  62. A. Mutvei, S. Kuzela, and B. D. Nelson, “Control of mitochondrial transcription by thyroid hormone,” European Journal of Biochemistry, vol. 180, no. 1, pp. 235–240, 1989. View at Publisher · View at Google Scholar · View at Scopus
  63. P. D. M. Rosaroll, V. Di Maio, M. Valente, S. Di Meo, and T. de Leo, “Thyroid hormone and the mitochondrial population in the rat heart,” Journal of Endocrinological Investigation, vol. 11, no. 8, pp. 559–565, 1988. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Di Meo, P. de Martino Rosaroll, and T. De Leo, “Effect of thyroid state on the morphofunctional properties of heart mitochondria,” Cellular Physiology and Biochemistry, vol. 2, no. 5, pp. 283–292, 1992. View at Publisher · View at Google Scholar
  65. E. Novo and M. Parola, “Redox mechanisms in hepatic chronic wound healing and fibrogenesis,” Fibrogenesis & Tissue Repair, vol. 1, no. 1, article 5, 2008. View at Publisher · View at Google Scholar
  66. D. Baraldi, K. Casali, R. O. Fernandes et al., “The role of AT1-receptor blockade on reactive oxygen species and cardiac autonomic drive in experimental hyperthyroidism,” Autonomic Neuroscience: Basic and Clinical, vol. 177, no. 2, pp. 163–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Pacher, R. Schulz, L. Liaudet, and C. Szabó, “Nitrosative stress and pharmacological modulation of heart failure,” Trends in Pharmacological Sciences, vol. 26, no. 6, pp. 302–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. U. Landmesser, S. Dikalov, S. R. Price et al., “Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension,” The Journal of Clinical Investigation, vol. 111, no. 8, pp. 1201–1209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Takimoto, H. C. Champion, M. Li et al., “Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1221–1231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Masullo, P. Venditti, C. Agnisola, and S. di Meo, “Role of nitric oxide in the reperfusion induced injury in hyperthyroid rat hearts,” Free Radical Research, vol. 32, no. 5, pp. 411–421, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Venditti, R. de Rosa, L. Cigliano, C. Agnisola, and S. Di Meo, “Role of nitric oxide in the functional response to ischemia-reperfusion of heart mitochondria from hyperthyroid rats,” Cellular and Molecular Life Sciences, vol. 61, no. 17, pp. 2244–2252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Quesada, J. Sainz, R. Wangensteen, I. Rodriguez-Gomez, F. Vargas, and A. Osuna, “Nitric oxide synthase activity in hyperthyroid and hypothyroid rats,” European Journal of Endocrinology, vol. 147, no. 1, pp. 117–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. A. L. Fellet, P. Arza, N. Arreche, C. Arranz, and A. M. Balaszczuk, “Nitric oxide and thyroid gland: modulation of cardiovascular function in automatic-blocked anaesthetized rats,” Experimental Physiology, vol. 89, no. 3, pp. 303–312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Ukai, C.-P. Cheng, H. Tachibana et al., “Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure,” Circulation, vol. 103, no. 5, pp. 750–755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. U. E. G. Ekelund, R. W. Harrison, O. Shokek et al., “Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure,” Circulation Research, vol. 85, no. 5, pp. 437–445, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. T. P. Cappola, D. A. Kass, G. S. Nelson et al., “Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy,” Circulation, vol. 104, no. 20, pp. 2407–2411, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Huh, T.-H. Kwon, J.-S. Kim, and J. M. Park, “Role of the hepatic xanthine oxidase in thyroid dysfunction: effect of thyroid hormones in oxidative stress in rat liver,” Archives of Pharmacal Research, vol. 21, no. 3, pp. 236–240, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Bartalena, M. L. Tanda, E. Piantanida, and A. Lai, “Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications,” BioFactors, vol. 19, no. 3-4, pp. 155–163, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. E. A. Bouzas, P. Karadimas, G. Mastorakos, and D. A. Koutras, “Antioxidant agents in the treatment of Graves' ophthalmopathy,” American Journal of Ophthalmology, vol. 129, no. 5, pp. 618–622, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Kawada, Y. Shirakawa, Y. Yoshimura, and M. Nishida, “Thyroid xanthine oxidase and its role in thyroid iodine metabolism in the rat: difference between effects of allopurinol and tungstate,” The Journal of Endocrinology, vol. 95, no. 1, pp. 117–124, 1982. View at Publisher · View at Google Scholar · View at Scopus
  81. O. Makay, C. Yenisey, G. Icoz et al., “The role of allopurinol on oxidative stress in experimental hyperthyroidism,” Journal of Endocrinological Investigation, vol. 32, no. 8, pp. 641–646, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. N. Aspromonte, F. Monitillo, A. Puzzovivo, R. Valle, P. Caldarola, and M. Iacoviello, “Modulation of cardiac cytochrome P450 in patients with heart failure,” Expert Opinion on Drug Metabolism and Toxicology, vol. 10, no. 3, pp. 327–339, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. A. A. El-Sherbeni and A. O. S. El-Kadi, “Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy,” Biochemical Pharmacology, vol. 87, no. 3, pp. 456–466, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Adameova, Y. Abdellatif, and N. S. Dhalla, “Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 7, pp. 493–514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. G. S. Levey, “Catecholamine sensitivity, thyroid hormone and the heart, a reevaluation,” The American Journal of Medicine, vol. 50, no. 4, pp. 413–420, 1971. View at Publisher · View at Google Scholar · View at Scopus
  86. L. W. Hu, L. A. Benvenuti, E. A. Liberti, M. S. Carneiro-Ramos, and M. L. M. Barreto-Chaves, “Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 285, no. 6, pp. R1473–R1480, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. A. M. Gerdes, J. A. Moore, and S. P. Bishop, “Failure of propranolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat,” The Canadian Journal of Cardiology, vol. 1, no. 5, pp. 340–345, 1985. View at Google Scholar · View at Scopus
  88. I. Klein, “Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol,” Endocrinology, vol. 123, no. 1, pp. 203–210, 1988. View at Publisher · View at Google Scholar · View at Scopus
  89. M. López-Torres, M. Romero, and G. Barja, “Effect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart,” Molecular and Cellular Endocrinology, vol. 168, no. 1-2, pp. 127–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. C. Richter, J.-W. Park, and B. N. Ames, “Normal oxidative damage to mitochondrial and nuclear DNA is extensive,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 17, pp. 6465–6467, 1988. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Lu, H. M. Nash, and G. L. Verdine, “A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer,” Current Biology, vol. 7, no. 6, pp. 397–407, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Yamaguchi, T. Hirano, S. Asami, A. Sugita, and H. Kasai, “Increase in the 8-hydroxyguanine repair activity in the rat kidney after the administration of a renal carcinogen, ferric nitrilotriacetate,” Environmental Health Perspectives, vol. 104, no. 3, pp. 651–653, 1996. View at Publisher · View at Google Scholar · View at Scopus
  93. F. J. Giordano, “Oxygen, oxidative stress, hypoxia, and heart failure,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 500–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. Y. Wang, B. Jiao, W. Guo, H. Che, and Z. Yu, “Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes,” Molecular and Cellular Endocrinology, vol. 320, no. 1-2, pp. 67–75, 2010. View at Publisher · View at Google Scholar
  95. K. Itoh, K. I. Tong, and M. Yamamoto, “Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles,” Free Radical Biology and Medicine, vol. 36, no. 10, pp. 1208–1213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. S. E. Purdom-Dickinson, E. V. Sheveleva, H. Sun, and Q. M. Chen, “Translational control of Nrf2 protein in activation of antioxidant response by oxidants,” Molecular Pharmacology, vol. 72, no. 4, pp. 1074–1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. T. Satoh, N. Harada, T. Hosoya, K. Tohyama, M. Yamamoto, and K. Itoh, “Keap1/Nrf2 system regulates neuronal survival as revealed through study of keap1 gene-knockout mice,” Biochemical and Biophysical Research Communications, vol. 380, no. 2, pp. 298–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Trachootham, W. Lu, M. A. Ogasawara, N. R.-D. Valle, and P. Huang, “Redox regulation of cell survival,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Fourquet, R. Guerois, D. Biard, and M. B. Toledano, “Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation,” The Journal of Biological Chemistry, vol. 285, no. 11, pp. 8463–8471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Yamamoto, G. Yang, C. Hong et al., “Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy,” The Journal of Clinical Investigation, vol. 112, no. 9, pp. 1395–1406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. R. J. Arai, F. T. Ogata, W. L. Batista et al., “Thioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases,” Toxicology and Applied Pharmacology, vol. 233, no. 2, pp. 227–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Kaur, G. Kaur, and M. P. Bansal, “Upregulation of AP1 by tertiary butyl hydroperoxide induced oxidative stress and subsequent effect on spermatogenesis in mice testis,” Molecular and Cellular Biochemistry, vol. 308, no. 1-2, pp. 177–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. D. K. Das, N. Maulik, and R. M. Engelman, “Redox regulation of angiotensin II signaling in the heart,” Journal of Cellular and Molecular Medicine, vol. 8, no. 1, pp. 144–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. C. L. Antos, T. A. McKinsey, N. Frey et al., “Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 907–912, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Kenessey and K. Ojamaa, “Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways,” The Journal of Biological Chemistry, vol. 281, no. 30, pp. 20666–20672, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Kobori, A. Ichihara, H. Suzuki et al., “Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 273, no. 2, pp. H593–H599, 1997. View at Google Scholar · View at Scopus
  108. H. Kobori, A. Ichihara, H. Suzuki, Y. Miyashita, M. Hayashi, and T. Saruta, “Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system,” American Journal of Physiology: Endocrinology and Metabolism, vol. 272, no. 2, pp. E227–E232, 1997. View at Google Scholar · View at Scopus
  109. M. S. Carneiro-Ramos, G. P. Diniz, A. P. Nadu et al., “Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation,” Basic Research in Cardiology, vol. 105, no. 3, pp. 325–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. J. Suzuki, “Growth factor signaling for cardioprotection against oxidative stress-induced apoptosis,” Antioxidants & Redox Signaling, vol. 5, no. 6, pp. 741–749, 2003. View at Publisher · View at Google Scholar
  111. F. Wang, Q. He, Y. Sun, X. Dai, and X. P. Yang, “Female adult mouse cardiomyocytes are protected against oxidative stress,” Hypertension, vol. 55, no. 5, pp. 1172–1178, 2010. View at Publisher · View at Google Scholar
  112. R. Aikawa, I. Komuro, T. Yamazaki et al., “Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats,” The Journal of Clinical Investigation, vol. 100, no. 7, pp. 1813–1821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Seven, O. Seymen, S. Hatemi, H. Hatemi, G. Yiğit, and G. Candan, “Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation,” Clinica Chimica Acta, vol. 256, no. 1, pp. 65–74, 1996. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Wang, J. Zhang, S. J. Walker, R. Dworakowski, E. G. Lakatta, and A. M. Shah, “Involvement of NADPH oxidase in age-associated cardiac remodeling,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 765–772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Haddad, S. A. Hunt, D. N. Rosenthal, and D. J. Murphy, “Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle,” Circulation, vol. 117, no. 11, pp. 1436–1448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. Hiroi, K. Fujiu, S. Komatsu et al., “Carvedilol therapy improved left ventricular function in a patient with arrhythmogenic right ventricular cardiomyopathy,” Japanese Heart Journal, vol. 45, no. 1, pp. 169–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  117. D. J. Grieve, J. A. Byrne, A. Siva et al., “Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload,” Journal of the American College of Cardiology, vol. 47, no. 4, pp. 817–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. B. Biondi, “Mechanisms in endocrinology: heart failure and thyroid dysfunction,” European Journal of Endocrinology, vol. 167, no. 5, pp. 609–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. F. Brandt, A. Green, L. Hegedüs, and T. H. Brix, “A critical review and meta-analysis of the association between overt hyperthyroidism and mortality,” European Journal of Endocrinology, vol. 165, no. 4, pp. 491–497, 2011. View at Publisher · View at Google Scholar · View at Scopus